Influence of administration timing of San-Huang-Xie-Xin-Tang treatment on attenuating Salmonella enterica serovar Typhimurium infection.

Salmonella infections are a serious global health concern, particularly in developing countries, and are further exacerbated by the emergence of antibiotic resistance. San-Huang-Xie-Xin-Tang (SHXXT), a traditional herbal medicine with potent anti-inflammatory properties, has recently gained attention as an alternative treatment. Our study emphasizes on the importance of precise timing in accordance with traditional Chinese medicine principles. A mouse infection model was established while different administration times of SHXXT were recorded for the body weight, clinical scores, bacterial counts in blood, and organs. Additionally, cytokine levels, fatty acids, and amino acids in the serum were also monitored. We found that administering SHXXT 1 day after Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) infection (T1 group) leads to positive outcomes. This includes restoration of body weight, improved clinical scores, and reduced bacterial counts in blood and vital organs. Interferon-gamma levels remained consistently high across all treatment groups 6 days post-infection. However, the T1 group showed exclusive suppression of serum levels of tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1ß). The timing of administration significantly influenced serum fatty acid concentrations, countering Salmonella-induced disruptions, aligning with TNF-α and IL-1ß levels. SHXXT had also restored amino acid profiles disrupted by the infection, with notable effects when administered at the correct timing. Our research highlights SHXXT's potential in treating S. Typhimurium infection, emphasizing the importance of precise timing in line with traditional Chinese medicine principles for effective treatment at different disease stages.

Cellular and molecular overview of gestational diabetes mellitus: Is it predictable and preventable?

BACKGROUND: In contrast to overt diabetes mellitus (DM), gestational DM (GDM) is defined as impaired glucose tolerance induced by pregnancy, which may arise from exaggerated physiologic changes in glucose metabolism. GDM prevalence is reported to be as high as 20% among pregnancies depending on the screening method, gestational age, and the population studied. Maternal and fetal effects of uncontrolled GDM include stillbirth, macrosomia, neonatal diabetes, birth trauma, and subsequent postpartum hemorrhage. Therefore, it is essential to find the potential target population and associated predictive and preventive measures for future intensive peripartum care. AIM: To review studies that explored the cellular and molecular mechanisms of GDM as well as predictive measures and prevention strategies. METHODS: The search was performed in the Medline and PubMed databases using the terms "gestational diabetes mellitus," "overt diabetes mellitus," and "insulin resistance." In the literature, only full-text articles were considered for inclusion (237 articles). Furthermore, articles published before 1997 and duplicate articles were excluded. After a final review by two experts, all studies (1997-2023) included in the review met the search terms and search strategy (identification from the database, screening of the studies, selection of potential articles, and final inclusion). RESULTS: Finally, a total of 79 articles were collected for review. Reported risk factors for GDM included maternal obesity or overweight, pre-existing DM, and polycystic ovary syndrome. The pathophysiology of GDM involves genetic variants responsible for insulin secretion and glycemic control, pancreatic ß cell depletion or dysfunction, aggravated insulin resistance due to failure in the plasma membrane translocation of glucose transporter 4, and the effects of chronic, low-grade inflammation. Currently, many antepartum measurements including adipokines (leptin), body mass ratio (waist circumference and waist-to-hip ratio], and biomarkers (microRNA in extracellular vesicles) have been studied and confirmed to be useful markers for predicting GDM. For preventing GDM, physical activity and dietary approaches are effective interventions to control body weight, improve glycemic control, and reduce insulin resistance. CONCLUSION: This review explored the possible factors that influence GDM and the underlying molecular and cellular mechanisms of GDM and provided predictive measures and prevention strategies based on results of clinical studies.

Synthesis of a novel solid mediator Z-scheme heterojunction photocatalysis Fe3O4/C/uio66-nh2: Used for oxidation of Rh6G in water.

A novel mediator Z-scheme photocatalyst, Fe3O4/C/UiO-66-NH2, was designed, synthesized, and characterized using SEM, TEM, FTIR, XRD, EPR, and XPS. Formulas #1 to #7 were examined using dye Rh6G dropwise tests. Carbonization of glucose forms the mediator carbon, which connects two semiconductors, Fe3O4 and UiO-66-NH2, to construct the Z-scheme photocatalyst. Formula #1 generates a composite with photocatalyst activity. The band gap measurements of the constituent semiconductors support the mechanisms for the Rh6G degradation using this novel Z-scheme photocatalyst. The successful synthesis and characterization of the proposed novel Z-scheme confirm the feasibility of the tested design protocol for environmental purposes.

Synthesis of a novel solid mediator Z-scheme heterojunction photocatalysis CuFe2O4/Cu/UiO-66-NH2 for oxidation of dye in water.

Metal mediator Z-scheme photocatalyst comprises three elements: two semiconductors and a sandwiched metal mediator, so the catalyst can effectively degrade pollutants using visible lights. Proper design and synthesis of Z-scheme with targeted performance has not been systematically proposed. This work proposed the protocol to design and synthesize a Z-scheme photocatalyst with targeted performance. A novel metal mediator Z-scheme photocatalyst CuFe2O4/Cu/UiO-66-NH2 was used to implement the design proposal. After determining synthesis protocol from the theory, the concentrations of three reagents - glucose, l-cysteine, and precursor of UiO-66-NH2 for synthesizing Z-scheme photocatalyst were revised to achieve successful photocatalyst. Dropwise photocatalytic tests were performed to confirm the activities of the synthesized catalysts using 0.112 mmol/mL UiO-66-NH2 precursor, 10 mmol/mL glucose, and 1 mmol/mL l-cysteine yielded effective photocatalyst to degrade rhodamine 6G. The dye degradation tests and EPR tests confirmed the successful synthesis of the designed Z-scheme photocatalyst.

Pollutant degradation with mediator Z-scheme heterojunction photocatalyst in water: A review.

The Z-scheme heterojunction is a photocatalyst with narrow band gap and sufficiently high oxidization and reduction powers for degradation of pollutants in waters. This review firstly summarizes the fundamentals of photocatalysis, and explains the need to develop Z-scheme heterojunctions to harvest energy from sunlight effectively. Secondly, contemporary reports of degradation wastewater pollutants, including organic dyes, antibiotics, and other chemicals are reviewed and discussed. A challenge in the selection of an appropriate Z-scheme for removing a specific pollutant is the lack of available energy levels that are offered by the catalyst and the lack of redox energy levels that are required to break down essential chemical bonds of the pollutants. With reference to the redox energy levels offered by the active photocatalytic species, the redox energy levels of specific pollutants studied in literature are estimated. Challenges and prospects concerning the use of the Z-scheme to degrade recalcitrant pollutants under irradiation by sunlight are outlined at the end of this review.

The Suppressive Effects of Geniposide and Genipin on Helicobacter pylori Infections In Vitro and In Vivo.

Geniposide and genipin have been found in Gardenia jasminoides Ellis, a traditional Chinese medicine that exhibits multiple biological functions. However, no report showing the effects of geniposide and genipin on gastric protection in Helicobacter pylori infections in vitro and in vivo has been done. In this study, we clarified how geniposide and genipin suppress H. pylori-mediated inflammation in gastric AGS cells and C57BL/6 mice. Our results demonstrated that genipin shows a strong ability to inhibit H. pylori growth and is able to reduce vacA and cagA gene expression of H. pylori in infected AGS cells. Genipin also attenuates the abilities of adhesion and invasion of H. pylori to AGS cells. An attenuation of interleukin (IL)-8 and IFN-γ production caused by genipin was observed to inhibit cell inflammatory responses. In the in vivo experiments, geniposide and genipin both showed suppressive effects on the vacA gene expression in mice after H. pylori infection. The serum levels of IFN-γ, IL-1ß, immunoglobulin A, and Immunoglobulin M were decreased by geniposide and genipin in infected mice. The inflammatory maker COX2 was downregulated in H. pylori-infected mice after exposure to geniposide and genipin. Together, geniposide and genipin effectively exert a healthy promotion to reduce H. pylori infections in vivo by interfering with the growth and virulence of H. pylori as well as attenuating the gastric inflammation caused by an H. pylori infection. PRACTICAL APPLICATION: Geniposide and genipin have a healthy promotion to eradicate H. pylori infections by interfering with the growth and virulence of H. pylori and to attenuate the gastric inflammation caused by an H. pylori infection.